Depending on the presence or absence of target molecules such as androgen receptors, PGRMC1, and the PI3K/AKT/mTOR pathway, breast cancer is most commonly classified into three categories: estrogen receptor (ER)-positive/ERBB2-positive, ERBB2-negative, and triple-negative breast cancer. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.